Similar articles for PMID: 20625290

Year	Number of Results
2000	1
2001	2
2003	2
2004	4
2005	4
2006	5
2007	2
2008	3
2009	10
2010	8
2011	4
2012	6
2013	4
2014	9
2015	7
2016	4
2017	7
2018	3
2019	5
2020	6
2021	4
2022	2
2024	0

1

Aldosterone blockade in chronic kidney disease: can it improve outcome?

Toto RD. Toto RD. Curr Opin Nephrol Hypertens. 2010 Sep;19(5):444-9. doi: 10.1097/MNH.0b013e32833ce6d5. Curr Opin Nephrol Hypertens. 2010. PMID: 20625290 Free PMC article. Review.

2

Change in proteinuria after adding aldosterone blockers to ACE inhibitors or angiotensin receptor blockers in CKD: a systematic review.

Bomback AS, Kshirsagar AV, Amamoo MA, Klemmer PJ. Bomback AS, et al. Am J Kidney Dis. 2008 Feb;51(2):199-211. doi: 10.1053/j.ajkd.2007.10.040. Am J Kidney Dis. 2008. PMID: 18215698 Review.

3

Aldosterone antagonists for preventing the progression of chronic kidney disease.

Bolignano D, Palmer SC, Navaneethan SD, Strippoli GF. Bolignano D, et al. Cochrane Database Syst Rev. 2014 Apr 29;(4):CD007004. doi: 10.1002/14651858.CD007004.pub3. Cochrane Database Syst Rev. 2014. PMID: 24782282 Updated. Review.

4

Mineralcorticoid receptor blockers in chronic kidney disease.

Erraez S, López-Mesa M, Gómez-Fernández P. Erraez S, et al. Nefrologia (Engl Ed). 2021 May-Jun;41(3):258-275. doi: 10.1016/j.nefroe.2021.08.001. Epub 2021 Sep 1. Nefrologia (Engl Ed). 2021. PMID: 36166243 Free article. Review.

5

Antagonists of aldosterone and proteinuria in patients with CKD: an uncontrolled pilot study.

Bianchi S, Bigazzi R, Campese VM. Bianchi S, et al. Am J Kidney Dis. 2005 Jul;46(1):45-51. doi: 10.1053/j.ajkd.2005.03.007. Am J Kidney Dis. 2005. PMID: 15983956 Clinical Trial.

6

Aldosterone blockade in chronic kidney disease.

Hirsch JS, Drexler Y, Bomback AS. Hirsch JS, et al. Semin Nephrol. 2014 May;34(3):307-22. doi: 10.1016/j.semnephrol.2014.04.006. Epub 2014 Apr 18. Semin Nephrol. 2014. PMID: 25016401 Review.

7

Mineralcorticoid receptor blockers in chronic kidney disease.

Erraez S, López-Mesa M, Gómez-Fernández P. Erraez S, et al. Nefrologia (Engl Ed). 2021 May-Jun;41(3):258-275. doi: 10.1016/j.nefro.2020.10.001. Epub 2020 Dec 24. Nefrologia (Engl Ed). 2021. PMID: 33358451 Free article. Review. English, Spanish.

8

Mineralocorticoid receptor blockers and chronic kidney disease.

Jain G, Campbell RC, Warnock DG. Jain G, et al. Clin J Am Soc Nephrol. 2009 Oct;4(10):1685-91. doi: 10.2215/CJN.01340209. Epub 2009 Sep 3. Clin J Am Soc Nephrol. 2009. PMID: 19729430 Review.

9

Mineralocorticoid receptor blockade in addition to angiotensin converting enzyme inhibitor or angiotensin II receptor blocker treatment: an emerging paradigm in diabetic nephropathy: a systematic review.

Mavrakanas TA, Gariani K, Martin PY. Mavrakanas TA, et al. Eur J Intern Med. 2014 Feb;25(2):173-6. doi: 10.1016/j.ejim.2013.11.007. Epub 2013 Dec 4. Eur J Intern Med. 2014. PMID: 24315413 Review.

10

Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis.

Navaneethan SD, Nigwekar SU, Sehgal AR, Strippoli GF. Navaneethan SD, et al. Clin J Am Soc Nephrol. 2009 Mar;4(3):542-51. doi: 10.2215/CJN.04750908. Epub 2009 Mar 4. Clin J Am Soc Nephrol. 2009. PMID: 19261819 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

93 results

Results by year